Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 65 announcements

Share price
₹833.80
Market cap
₹16,389 Cr
Revenue (annual)
₹7,345 Cr
Net profit (annual)
₹674.8 Cr
P/E (TTM)
23.6×Sector 47.3×
Promoter holding
69.87%+0.13% QoQ
FII holding
4.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:01 IST BSE
Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals Limited has appointed Mr. Chirag Shukla as the Company Secretary and Compliance Officer (Key Managerial Personnel), effective 20th August, 2026.

19:00 IST BSE
Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals' Company Secretary and Compliance Officer, Ms. Manisha Saraf, has resigned from her position effective August 10, 2026.

18:55 IST BSE
Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals announced that Atul Suri and Prag Goel ceased being Senior Management Personnel following an internal reporting restructure. This administrative shift streamlines the company's India business reporting.

18:57 IST BSE
Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals appointed Mr. Ramesh Juneja as Executive Vice President and Senior Management Personnel. He brings three decades of pharmaceutical sales and marketing experience.

18:58 IST BSE
Management Change

Alembic Pharmaceuticals Management Change

Mr. Rohit Garg resigned as Senior Vice President at Alembic Pharmaceuticals effective May 14, 2026. His departure for personal reasons marks a change in senior management.

19:35 IST NSE
Management Change

Alembic Pharmaceuticals Management Change

Mr. Goldee Pardesi has resigned as Associate Vice President - Sales & Marketing at Alembic Pharmaceuticals Limited, effective May 5, 2026. He is leaving to pursue new professional challenges and personal goals. The company has formally disclosed this cessation of senior management personnel to the exchanges.

19:47 IST NSE
Management Change

Alembic Pharmaceuticals Management Change

Mr. Goldee Pardesi has resigned as Associate Vice President - Sales & Marketing at Alembic Pharmaceuticals Limited, effective May 5, 2026. He is leaving to pursue new professional challenges and personal goals. The company reported this cessation under the Senior Management Personnel category.

19:28 IST BSE
Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals Limited announced the resignation of Mr. Goldee Pardesi, Associate Vice President – Sales & Marketing. He was relieved from his duties effective close of business hours on May 4, 2026, to pursue other professional opportunities. The departure is part of a standard senior management transition.

10:50 IST NSE
Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals Limited has appointed Mr. Amit Nayak as Vice President - Commercial Excellence, effective May 1, 2026. Mr. Nayak brings 12 years of experience from firms including Cipla and EY. He will lead commercial excellence initiatives through digital enablement and optimized sales operations.

10:43 IST NSE
Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals Limited has appointed Mr. Amit Nayak as Vice President - Commercial Excellence, effective May 1, 2026. Mr. Nayak brings 12 years of experience from firms like Cipla and EY. He will lead commercial excellence through optimized sales operations and digital enablement.

10:39 IST BSE
Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals has designated Mr. Amit Nayak, Vice President - Commercial Excellence, as Senior Management Personnel effective May 1, 2026. Mr. Nayak brings 12 years of experience from firms including J B Chemicals, Cipla, and EY. This designation aligns with SEBI listing regulations regarding senior management disclosures.

12:51 IST NSE
Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals Limited announced the demise of Mr. Saibal Mukherjee, Resident Director (General Manager - Corporate Relations), on April 26, 2026. Mr. Mukherjee was a Senior Management Personnel based at the company's Delhi office.

12:23 IST NSE
Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals Limited announced the sad demise of Mr. Saibal Mukherjee, Resident Director (Delhi Office), on April 26, 2026. Mr. Mukherjee joined the company in 2014 and was an integral part of the senior management team. The company expressed deep condolences to his family for this irreparable loss.